Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rilan Bai

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Frontiers in Immunology|July 14, 2022
Development of Immunotherapy Strategies Targeting Tumor Microenvironment Is Fiercely OngoingRilan Bai, Jiuwei Cui
Cancer Letters|May 12, 2023
Mitochondrial immune regulation and anti-tumor immunotherapy strategies targeting mitochondriaRilan Bai, Jiuwei Cui
Frontiers in Immunology|May 31, 2022
Burgeoning Exploration of the Role of Natural Killer Cells in Anti-PD-1/PD-L1 TherapyRilan Bai, Jiuwei Cui
Chinese Medical Journal|January 26, 2024
Regulation of fatty acid synthase on tumor and progress in the development of related therapiesRilan Bai, Jiuwei Cui
Cancer Biology & Medicine|October 17, 2022
Potential new applications of immunotherapy for neuroendocrine neoplasms: immune landscape, current status and future perspectivesRilan Bai, Wenqian Li, Jiuwei Cui
Thoracic Cancer|April 3, 2023
Precision targeted therapy for EGFR mutation-positive NSCLC: Dilemmas and coping strategiesYing Meng, Rilan Bai, Jiuwei Cui
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|November 28, 2019
[Targeted Therapies for Driver Gene Mutation-positive Lung Cancer Patients with Brain Metastasis]Wenqian Li, Rilan Bai, Jiuwei Cui
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|February 26, 2020
[Advances in Combination Therapy of Immune Checkpoint Inhibitors for Lung Cancer]Hanfei Guo, Rilan Bai, Jiuwei Cui
Critical Reviews in Oncology/Hematology|May 26, 2023
Therapeutic strategies targeting metabolic characteristics of cancer cellsRilan Bai, Ying Meng, Jiuwei Cui
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|September 3, 2018
[Study Progression on Non-small Cell Lung Cancer with EGFR Mutation 
Treated by Immune Checkpoint Inhibitors]Rilan Bai, Naifei Chen, Jiuwei Cui
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Frontiers in Immunology|July 14, 2022
Development of Immunotherapy Strategies Targeting Tumor Microenvironment Is Fiercely OngoingRilan Bai, Jiuwei Cui
Cancer Letters|May 12, 2023
Mitochondrial immune regulation and anti-tumor immunotherapy strategies targeting mitochondriaRilan Bai, Jiuwei Cui
Frontiers in Immunology|May 31, 2022
Burgeoning Exploration of the Role of Natural Killer Cells in Anti-PD-1/PD-L1 TherapyRilan Bai, Jiuwei Cui
Chinese Medical Journal|January 26, 2024
Regulation of fatty acid synthase on tumor and progress in the development of related therapiesRilan Bai, Jiuwei Cui
Cancer Biology & Medicine|October 17, 2022
Potential new applications of immunotherapy for neuroendocrine neoplasms: immune landscape, current status and future perspectivesRilan Bai, Wenqian Li, Jiuwei Cui
Thoracic Cancer|April 3, 2023
Precision targeted therapy for EGFR mutation-positive NSCLC: Dilemmas and coping strategiesYing Meng, Rilan Bai, Jiuwei Cui
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|November 28, 2019
[Targeted Therapies for Driver Gene Mutation-positive Lung Cancer Patients with Brain Metastasis]Wenqian Li, Rilan Bai, Jiuwei Cui
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|February 26, 2020
[Advances in Combination Therapy of Immune Checkpoint Inhibitors for Lung Cancer]Hanfei Guo, Rilan Bai, Jiuwei Cui
Critical Reviews in Oncology/Hematology|May 26, 2023
Therapeutic strategies targeting metabolic characteristics of cancer cellsRilan Bai, Ying Meng, Jiuwei Cui
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|September 3, 2018
[Study Progression on Non-small Cell Lung Cancer with EGFR Mutation 
Treated by Immune Checkpoint Inhibitors]Rilan Bai, Naifei Chen, Jiuwei Cui
Pageof 3